b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30420421</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>03</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>09</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1533-3450</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>29</Volume>\n                    <Issue>12</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>12</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of the American Society of Nephrology : JASN</Title>\n                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>2890-2899</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.2018040443</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">The comparative effectiveness of treatment with angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or their combination in people with albuminuria and cardiovascular risk factors is unclear.</AbstractText>\n                <AbstractText Label="METHODS">In a multicenter, randomized, open label, blinded end point trial, we evaluated the effectiveness on cardiovascular events of ACE or ARB monotherapy or combination therapy, targeting BP&lt;130/80 in patients with moderate or severe albuminuria and diabetes or other cardiovascular risk factors. End points included a primary composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and hospitalization for cardiovascular causes and a revised end point of all-cause mortality. Additional end points included ESRD, doubling of serum creatinine, albuminuria, eGFR, BP, and adverse events.</AbstractText>\n                <AbstractText Label="RESULTS">Because of slow enrollment, the trial was modified and stopped 41% short of targeted enrollment of 2100 participants, corresponding to 35% power to detect a 25% reduced risk in the primary outcome. Our analysis included 1243 adults, with median follow-up of 2.7 years. Efficacy outcomes were similar between groups (ACE inhibitor versus ARB, ACE inhibitor versus combination, ARB versus combination) as were rates of serious adverse events. The rate of permanent discontinuation for ARB monotherapy (6.3%) was significantly lower than for ACE inhibitor monotherapy (15.7%) or combined therapy (18.3%).</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Patients may tolerate ARB monotherapy better than ACE inhibitor monotherapy. However, data from this trial and similar trials, although as yet inconclusive, show no trend suggesting differences in mortality and renal outcomes with ACE inhibitors or ARBs as dual or monotherapy in patients with albuminuria and diabetes or other cardiovascular risk factors.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 by the American Society of Nephrology.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Saglimbene</LastName>\n                    <ForeName>Valeria</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sydney School of Public Health, Faculty of Medicine and Health, Sydney, Australia.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Scientific Office, Diaverum Renal Services Group, Lund, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Palmer</LastName>\n                    <ForeName>Suetonia C</ForeName>\n                    <Initials>SC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ruospo</LastName>\n                    <ForeName>Marinella</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Scientific Office, Diaverum Renal Services Group, Lund, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Natale</LastName>\n                    <ForeName>Patrizia</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Scientific Office, Diaverum Renal Services Group, Lund, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Emergency and Organ Transplantation and.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Maione</LastName>\n                    <ForeName>Ausilia</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Freelance Consultant (formerly Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Chieti, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Nicolucci</LastName>\n                    <ForeName>Antonio</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Vecchio</LastName>\n                    <ForeName>Mariacristina</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Hydration and Health, Danone Research, Palaiseau, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tognoni</LastName>\n                    <ForeName>Gianni</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Craig</LastName>\n                    <ForeName>Jonathan C</ForeName>\n                    <Initials>JC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sydney School of Public Health, Faculty of Medicine and Health, Sydney, Australia.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>College of Medicine and Public Health, Flinders University, Health Sciences Building, Adelaide 5001, South Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pellegrini</LastName>\n                    <ForeName>Fabio</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Worldwide Medical, Biogen, Cambridge, Massachusetts.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lucisano</LastName>\n                    <ForeName>Giuseppe</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hegbrant</LastName>\n                    <ForeName>J\xc3\xb6rgen</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Scientific Office, Diaverum Renal Services Group, Lund, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ariano</LastName>\n                    <ForeName>Rosario</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology and Dialysis, Azienda Ospedaliera Instituti Ospedalieri di Cremona, Cremona, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Lamacchia</LastName>\n                    <ForeName>Olga</ForeName>\n                    <Initials>O</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology, Azienda Ospedaliera Universitaria Foggia, Foggia, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sasso</LastName>\n                    <ForeName>Antonio</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medicine, Ospedale Civile S. Pellegrino, Trani, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Morano</LastName>\n                    <ForeName>Susanna</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical Sciences, Azienda Policlinico Umberto I-Universit\xc3\xa0 La Sapienza, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Filardi</LastName>\n                    <ForeName>Tiziana</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical Sciences, Azienda Policlinico Umberto I-Universit\xc3\xa0 La Sapienza, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>De Cosmo</LastName>\n                    <ForeName>Salvatore</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Sciences, Scientific Institute Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pugliese</LastName>\n                    <ForeName>Giuseppe</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Clinical and Molecular Medicine, &quot;La Sapienza&quot; University, Rome, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Procaccini</LastName>\n                    <ForeName>Deni A</ForeName>\n                    <Initials>DA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Division of Nephrology, University of Foggia, Foggia, Italy; Departments of.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gesualdo</LastName>\n                    <ForeName>Loreto</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Emergency and Organ Transplantation and.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Palasciano</LastName>\n                    <ForeName>Giuseppe</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Internal Medicine, University of Bari, Bari, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Johnson</LastName>\n                    <ForeName>David W</ForeName>\n                    <Initials>DW</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Nephrology, University of Queensland at Princess Alexandra Hospital, Brisbane, Australia.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tonelli</LastName>\n                    <ForeName>Marcello</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Research Office of the Vice-President, Cumming School of Medicine, University of Calgary, Calgary, Canada; and.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Strippoli</LastName>\n                    <ForeName>Giovanni F M</ForeName>\n                    <Initials>GFM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Sydney School of Public Health, Faculty of Medicine and Health, Sydney, Australia; gfmstrippoli@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Scientific Office, Diaverum Renal Services Group, Lund, Sweden.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Emergency and Organ Transplantation and.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Diaverum Academy, Bari, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <CollectiveName>Long-Term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) Investigators</CollectiveName>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>12</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>J Am Soc Nephrol</MedlineTA>\n            <NlmUniqueID>9013836</NlmUniqueID>\n            <ISSNLinking>1046-6673</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D057911">Angiotensin Receptor Antagonists</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000419" MajorTopicYN="N">Albuminuria</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D057911" MajorTopicYN="N">Angiotensin Receptor Antagonists</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName>\n                <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName>\n                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">albuminuria</Keyword>\n            <Keyword MajorTopicYN="Y">clinical trial</Keyword>\n            <Keyword MajorTopicYN="Y">diabetic nephropathy</Keyword>\n            <Keyword MajorTopicYN="Y">end-stage renal disease</Keyword>\n            <Keyword MajorTopicYN="Y">mortality</Keyword>\n            <Keyword MajorTopicYN="Y">renin angiotensin system</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>04</Month>\n                <Day>27</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>04</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>9</Month>\n                <Day>4</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>11</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30420421</ArticleId>\n            <ArticleId IdType="pii">ASN.2018040443</ArticleId>\n            <ArticleId IdType="doi">10.1681/ASN.2018040443</ArticleId>\n            <ArticleId IdType="pmc">PMC6287867</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Diabetes Care. 2006 Jan;29 Suppl 1:S4-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16373931</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Nephrol. 2007 Nov-Dec;20(6):646-55</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18046666</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2004 Nov 4;351(19):1952-61</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15516696</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Hypertension. 2005 Apr;45(4):659-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15723969</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2015 May 23;385(9982):2047-56</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26009228</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2008 Aug 16;372(9638):547-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18707986</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Adv Ther. 2005 Mar-Apr;22(2):155-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16020405</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Kidney Int. 2000 Aug;58(2):762-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10916100</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Diabetes Care. 2017 Sep;40(9):1273-1284</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28830958</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2003 May 21;289(19):2560-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12748199</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2008 Apr 10;358(15):1547-59</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18378520</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Clin Pract. 1999 Dec;53(8):584-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10692751</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2013 Nov 14;369(20):1892-903</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24206457</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Soc Nephrol. 2009 Dec;20(12):2641-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19926893</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>BMJ. 2013 Oct 24;347:f6008</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24157497</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Hum Hypertens. 2005 Jun;19(6):429-37</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15647778</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2012 Dec 6;367(23):2204-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23121378</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'